
NanoVibronix, Inc. – NASDAQ:NAOV
NanoVibronix stock price today
NanoVibronix stock price monthly change
NanoVibronix stock price quarterly change
NanoVibronix stock price yearly change
NanoVibronix key metrics
Market Cap | 2.09M |
Enterprise value | 2.45M |
P/E | -0.73 |
EV/Sales | 1.50 |
EV/EBITDA | -0.41 |
Price/Sales | 2.69 |
Price/Book | 1.39 |
PEG ratio | 0.02 |
EPS | -1.70 |
Revenue | 2.85M |
EBITDA | -2.96M |
Income | -3.20M |
Revenue Q/Q | 160.16% |
Revenue Y/Y | 241.72% |
Profit margin | -359.91% |
Oper. margin | -356.91% |
Gross margin | 44.44% |
EBIT margin | -356.91% |
EBITDA margin | -104.14% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNanoVibronix stock price history
NanoVibronix stock forecast
NanoVibronix financial statements
Jun 2023 | 294K | -1.07M | -365.31% |
---|---|---|---|
Sep 2023 | 458K | -727K | -158.73% |
Dec 2023 | 1.17M | -813K | -69.07% |
Mar 2024 | 921K | -588K | -63.84% |
Jun 2023 | 3831000 | 2.66M | 69.59% |
---|---|---|---|
Sep 2023 | 7361000 | 2.67M | 36.29% |
Dec 2023 | 6674000 | 2.68M | 40.25% |
Mar 2024 | 6235000 | 2.73M | 43.8% |
Jun 2023 | -1.22M | 0 | 0 |
---|---|---|---|
Sep 2023 | -682K | -3.49M | 4.21M |
Dec 2023 | -491K | 3.49M | 0 |
Mar 2024 | -579K | -1K | 0 |
NanoVibronix alternative data
Aug 2023 | 9 |
---|---|
Sep 2023 | 9 |
Oct 2023 | 9 |
Nov 2023 | 9 |
Dec 2023 | 9 |
Jan 2024 | 9 |
Feb 2024 | 9 |
Mar 2024 | 9 |
Apr 2024 | 9 |
May 2024 | 10 |
Jun 2024 | 10 |
Jul 2024 | 10 |
NanoVibronix other data
Period | Buy | Sel |
---|---|---|
Jun 2022 | 46000 | 0 |
Jan 2023 | 50000 | 0 |
Insider | Compensation |
---|---|
Mr. Brian M. Murphy (1957) Chief Executive Officer & Director | $321,000 |
Mr. Stephen R. Brown CPA, CPA (1956) Chief Financial Officer & Accounting Officer | $207,500 |
-
What's the price of NanoVibronix stock today?
One share of NanoVibronix stock can currently be purchased for approximately $5.82.
-
When is NanoVibronix's next earnings date?
Unfortunately, NanoVibronix's (NAOV) next earnings date is currently unknown.
-
Does NanoVibronix pay dividends?
No, NanoVibronix does not pay dividends.
-
How much money does NanoVibronix make?
NanoVibronix has a market capitalization of 2.09M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 203.59% to 2.28M US dollars.
-
What is NanoVibronix's stock symbol?
NanoVibronix, Inc. is traded on the NASDAQ under the ticker symbol "NAOV".
-
What is NanoVibronix's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of NanoVibronix?
Shares of NanoVibronix can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are NanoVibronix's key executives?
NanoVibronix's management team includes the following people:
- Mr. Brian M. Murphy Chief Executive Officer & Director(age: 68, pay: $321,000)
- Mr. Stephen R. Brown CPA, CPA Chief Financial Officer & Accounting Officer(age: 69, pay: $207,500)
-
How many employees does NanoVibronix have?
As Jul 2024, NanoVibronix employs 10 workers, which is 11% more then previous quarter.
-
When NanoVibronix went public?
NanoVibronix, Inc. is publicly traded company for more then 10 years since IPO on 28 May 2015.
-
What is NanoVibronix's official website?
The official website for NanoVibronix is nanovibronix.com.
-
Where are NanoVibronix's headquarters?
NanoVibronix is headquartered at 525 Executive Boulevard, Elmsford, NY.
-
How can i contact NanoVibronix?
NanoVibronix's mailing address is 525 Executive Boulevard, Elmsford, NY and company can be reached via phone at +91 42333004.
NanoVibronix company profile:

NanoVibronix, Inc.
nanovibronix.comNASDAQ
10
Medical - Devices
Healthcare
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.
Elmsford, NY 10523
CIK: 0001326706
ISIN: US63008J6038
CUSIP: 63008J108